Calvin Ma

Array ( [id] => 7105783 [patent_doc_number] => 20050107590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Mutated constitutively active nuclear ophan receptor' [patent_app_type] => utility [patent_app_number] => 10/505183 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16246 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107590.pdf [firstpage_image] =>[orig_patent_app_number] => 10505183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821241 [patent_doc_number] => 20030219402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Chimeric molecules for cleavage in a treated host' [patent_app_type] => new [patent_app_number] => 10/367555 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29432 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219402.pdf [firstpage_image] =>[orig_patent_app_number] => 10367555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706763 [patent_doc_number] => 20030153497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Use of human not1and not1a orphan receptors' [patent_app_type] => new [patent_app_number] => 10/221909 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7477 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153497.pdf [firstpage_image] =>[orig_patent_app_number] => 10221909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585712 [patent_doc_number] => 07442684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Long-acting hormone and growth factor compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/357253 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12296 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442684.pdf [firstpage_image] =>[orig_patent_app_number] => 10357253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397030 [patent_doc_number] => 20040038862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Identification of new therapeutic targets for modulating bile acid synthesis' [patent_app_type] => new [patent_app_number] => 10/343289 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5110 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038862.pdf [firstpage_image] =>[orig_patent_app_number] => 10343289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7228641 [patent_doc_number] => 20050255529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor' [patent_app_type] => utility [patent_app_number] => 10/502893 [patent_app_country] => US [patent_app_date] => 2003-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33724 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255529.pdf [firstpage_image] =>[orig_patent_app_number] => 10502893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821244 [patent_doc_number] => 20030219405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Oral administration of interferon-tau' [patent_app_type] => new [patent_app_number] => 10/346269 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6134 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219405.pdf [firstpage_image] =>[orig_patent_app_number] => 10346269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796948 [patent_doc_number] => 20030175822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Opiate, cannabinoid, and estrogen receptors' [patent_app_type] => new [patent_app_number] => 10/338306 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14655 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175822.pdf [firstpage_image] =>[orig_patent_app_number] => 10338306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663651 [patent_doc_number] => 07101978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'TNF-α binding molecules' [patent_app_type] => utility [patent_app_number] => 10/338552 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 25999 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101978.pdf [firstpage_image] =>[orig_patent_app_number] => 10338552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769889 [patent_doc_number] => 20030215829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Nuclear hormone receptors' [patent_app_type] => new [patent_app_number] => 10/297653 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37463 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215829.pdf [firstpage_image] =>[orig_patent_app_number] => 10297653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405563 [patent_doc_number] => 20040105856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Use of histamine H4 receptor antagonist for the treatment of inflammatory responses' [patent_app_type] => new [patent_app_number] => 10/307874 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8853 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105856.pdf [firstpage_image] =>[orig_patent_app_number] => 10307874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851400 [patent_doc_number] => 20030143603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Anti-TNF antibodies, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/305347 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28534 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143603.pdf [firstpage_image] =>[orig_patent_app_number] => 10305347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397026 [patent_doc_number] => 20040038861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Methods and compositions for normalizing lipid levels in mammalian tissues' [patent_app_type] => new [patent_app_number] => 10/306645 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34969 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038861.pdf [firstpage_image] =>[orig_patent_app_number] => 10306645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468838 [patent_doc_number] => 20040102367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Gene expression system based on chimeric receptors' [patent_app_type] => new [patent_app_number] => 10/181325 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16634 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102367.pdf [firstpage_image] =>[orig_patent_app_number] => 10181325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769511 [patent_doc_number] => 20030215451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Composition comprising and method of using angiopoietin-like protein 3 Angptl3' [patent_app_type] => new [patent_app_number] => 10/298461 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26232 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215451.pdf [firstpage_image] =>[orig_patent_app_number] => 10298461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860543 [patent_doc_number] => 20030091551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Treatment of diabetes mellitus and insulin receptor signal transduction' [patent_app_type] => new [patent_app_number] => 10/269073 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14368 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091551.pdf [firstpage_image] =>[orig_patent_app_number] => 10269073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655796 [patent_doc_number] => 20030077645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Superfamily receptor chimeras, translocation assay for superfamily receptor ligands, and methods and kits for detecting and characterizing receptor ligands' [patent_app_type] => new [patent_app_number] => 10/259864 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13602 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077645.pdf [firstpage_image] =>[orig_patent_app_number] => 10259864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313466 [patent_doc_number] => 20040033600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Ecdysone receptor-based inducible gene expression system' [patent_app_type] => new [patent_app_number] => 10/239134 [patent_app_country] => US [patent_app_date] => 2002-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28079 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033600.pdf [firstpage_image] =>[orig_patent_app_number] => 10239134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363847 [patent_doc_number] => 20040091863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Regulation of human leukotriene b4-like g protein-coupled receptor' [patent_app_type] => new [patent_app_number] => 10/221555 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21637 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091863.pdf [firstpage_image] =>[orig_patent_app_number] => 10221555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7221583 [patent_doc_number] => 20040072368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Lipoprotein receptor' [patent_app_type] => new [patent_app_number] => 10/242686 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23517 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072368.pdf [firstpage_image] =>[orig_patent_app_number] => 10242686 [rel_patent_id] =>[rel_patent_doc_number] =>)